Delayed Infliximab Treatment Affects the Outcomes of Patients With Crohn's Disease During the COVID-19 Epidemic in China: A Propensity Score-Matched Analysis

Delayed Infliximab Treatment Affects the Outcomes of Patients With Crohn's Disease During the COVID-19 Epidemic in China: A Propensity Score-Matched Analysis

Background: The coronavirus disease 2019 (COVID-19) has swept the world and led to delays in the treatment of Crohn's disease patients treated with biologics. This study aims to investigate the risk factors for delayed treatment during the epidemic and to observe the short- and long-term influe...

Full description

Bibliographic Details
Main Authors: Yong Li, Lulu Chen, Shuijiao Chen, Xiaowei Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Medicine
Subjects:
COVID-19
infliximab
Crohn's disease
delayed treatment
readmission
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.819557/full

Similar Items

Similar Items